Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

August 14, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 14, 2026

Conditions
BleedingTransplant, KidneyDesmopressinKidney Biopsy
Interventions
DRUG

Desmopressin (DDAVP)

Patients in the intervention group will receive desmopressin 0.3ug/kg administered as an intravenous infusion 1h before the proposed procedure

DRUG

Sodium Chloride

Patients in the control group will receive sodium chloride 0.9% 100mL administered as an intravenous infusion 1h before the proposed procedure

Trial Locations (1)

90410000

Hospital de Clinicas de Porto Alegre, Porto Alegre

All Listed Sponsors
lead

Hospital de Clinicas de Porto Alegre

OTHER